Cardiometabolic multimorbidity might result in combined global cerebrovascular and neurodegenerative processes,42 whereas genetic risk is more closely related to pathways involving pathological protein tau and β-amyloid aggregation, which have hippocampal specificity, especially during early stages of Alzheimer's dementia.43 The gene discussed is MAPT; the disease is Alzheimer disease.